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Sarah Ratzel1 and Sara B. Cullinan2Optimized Southern Blot for Determining C9orf72
Repeat Expansion Size
Beck et al., page 345
The association between C9orf72 hexanucleotide repeat
expansions and diseases such as frontaltemporal lobar
degeneration (FLTD) and amyotrophic lateral sclerosis
(ALS) has received noteworthy attention recently.
However, defining the role of C9orf72 expansions in neu-
rodegeneration is complicated because it is difficult to
quantify the number of repeats and thus correlations
between repeat expansion number and phenotype are
often ambiguous. To sort out this puzzle, Beck et al.
used repeat-primed PCR and an optimized Southern blot
to determine the frequency of large repeats in disease
and control cohorts. Across six neurodegenerative
cohorts, large repeat expansions accounted for 7.5% of
FLTD, 1.2% of Alzheimer disease, 8.1% of ALS, 0.2% of
sporadic Creutzfeldt-Jakob disease, 1.7% of Huntington-
disease-like syndrome, and 2% of other neurodegenera-
tive diseases. Interestingly, there was a correlation
between the size of the expansion and the age of onset,
but not between expansion size and diagnostic group.
These expansions were also detected in 1/691 healthy
individuals and were associated with a risk haplotype
designated by rs3849942A. By ruling out a founder effect,
Beck and colleagues suggest that this haplotype might
confer an increased risk of mutation. Because of the
high number of carriers and the frequency of expansions
in several neurodegenerative diseases, the utility of a reli-
able method for quantifying expansion size, such as the
optimized Southern blot used in this work, will be
increasingly important as a diagnostic and investigative
tool.A SNP Slows Migration
Pu et al., page 366
Genome-wide association studies (GWASs) have
provided hints about genes that might be involved in
certain diseases and complex traits. However, the impact
of many significant SNPs remains speculative and
requires characterization for clarifying their biological
function. In this study, Pu et al. followed up on one
such SNP, rs3825807, which they identified in a popula-1Scientific Editor, AJHG; 2Deputy Editor, AJHG
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The Ametion-based study of atherosclerosis and which has
also recently been associated, by GWAS, with coronary
artery disease. This SNP is inversely associated with
atherosclerosis and changes an amino acid from a serine
(the A allele) to a proline (the G allele) in the prodo-
main of the protease ADAMTS7, which cleaves thrombo-
spondin-5, a protein that is produced by vascular
smooth muscle cells (VSMCs) and that inhibits their
own migration. Cells expressing the G allele were not
as efficient in cleaving thrombospondin-5, had reduced
accumulation of prodomain processing, and had
a reduced migratory ability. This is consistent with the
idea that the serine-to-proline substitution in the prodo-
main might interfere with ADAMTS7 maturation and
thus lead to reduced function in the variant encoded
by the G allele. Although the specific mechanism by
which reduced VSMC migration protects an individual
from atherosclerosis remains unclear, this study provides
insight into the more subtle functional differences that
can arise from nonsynonymous variants and serves as
an example of using specific GWAS data as a starting
point for in vivo characterization.Zooming In on CNVs
Chen et al., page 375
The neurexin proteins (NRXN1, NRXN2, and NRXN3)
play key roles in synapse formation and neurotransmis-
sion. It is perhaps not surprising, then, that NRXN1-
affecting microdeletions, which occur with high
frequency, confer risk of neurodevelopmental abnormali-
ties, including autism spectrum disorder and schizo-
phrenia. Owing to the variability of the size and location
of the deletions, however, the mechanism(s) that target
this region have remained unknown. In this study,
Chen et al. analyzed the breakpoints of over 30 NRXN1
deletions and propose that the presence of short inverted
repeats predisposes this region to genomic instability and
thus renders it a so-called deletion hotspot. Although the
authors’ analysis was limited to deletions affecting
NRXN1, these results should be of considerable interest
to investigators who are interested in better under-
standing the mechanisms that underlie complex patterns
of copy-number variation and their related genomic
disorders.y of Human Genetics. All rights reserved.
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A New Look at the Y
Mendez et al., page 454
Efforts to uncover the origins of anatomically modern hu-
mans have relied, in large part, on analyses of mtDNA and
the nonrecombining portion of the Y chromosome. These
studies have led to a well-accepted model that places the
originof ourmost recent commonancestors in sub-Saharan
Africa. Unsatisfyingly, however, timing estimates from the
female- and male-specific sequences differ by ~100,000
years. Although several potential explanations have been
put forth for the more ancient history of mtDNA lineages,
this discrepancy has unsettled many investigators. Now,
Mendez et al. report on the serendipitous discovery of a Y
chromosome that harbors the ancestral state of all known
SNPs. This finding led them to add a new root to the Y chro-
mosome phylogenetic tree, and they termed this lineage
A00. Armed with these findings, the authors developed
new estimates that suggest that the Y lineage is much older
than any previously identified mtDNA lineages. The
authors’ work is sure to send many investigators back into
the lab, where they will need to consider not only new
models for Y chromosome diversity, perhaps by drawing
upon knowledge of autosomal diversity, but also a reassess-
ment of exactly who our earliest ancestors were.314 The American Journal of Human Genetics 92, 313–314, March 7ONECUT Ahead
Funnell et al., page 460
Hemophilia B, also known as the ‘‘royal disease’’ for its
prevalence in descendants of England’s Queen Victoria,
is known to arise from mutations in coagulation factor
IX (F9). Although over 20 different mutations have
been identified in the F9 promoter region, the molecular
cause of this blood disease has remained a mystery for
many affected individuals. In this issue, Funnell et al.
demonstrate that a cluster of mutations in the F9
promoter disrupts binding of transcription factors
ONECUT1 (also known as HNF6) and ONECUT2. Mice
lacking these transcription factors died in utero, owing
to developmental defects. The authors showed that F9
expression was markedly reduced in these embryos;
notably, other liver-specific genes were expressed at
near normal levels, indicating that the reduced F9 levels
do not stem from a general failure in liver development.
The ONECUT proteins join HNF4 and C/EBPa as known
regulators of F9 expression, thus expanding our knowl-
edge of this liver-restricted transcriptional program. For
those with an appreciation of history, these findings
also solve a puzzle that has stymied geneticists for
many years., 2013
